Two Sigma Investments
IMGN

Two Sigma Investments’s Immunogen Inc IMGN Stock Holding History

Two Sigma Investments’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-363,900
Closed -$10.8M – 3498
2023
Q4 		$10.8M Sell
363,900
-1,264,317
-78% -$25.2M 0.02% 649
2023
Q3 		$25.8M Buy
1,628,217
+812,680
+100% +$13.5M 0.07% 321
2023
Q2 		$15.4M Sell
815,537
-838,865
-51% -$9.9M 0.04% 488
2023
Q1 		$6.35M Sell
1,654,402
-322,725
-16% -$1.38M 0.02% 795
2022
Q4 		$9.81M Sell
1,977,127
-447,630
-18% -$2.43M 0.03% 566
2022
Q3 		$11.6M Buy
2,424,757
+399,130
+20% +$2.1M 0.04% 446
2022
Q2 		$9.12M Sell
2,025,627
-60,205
-3% -$262K 0.03% 553
2022
Q1 		$9.93M Sell
2,085,832
-474,942
-19% -$2.63M 0.03% 610
2021
Q4 		$19M Buy
2,560,774
+494,108
+24% +$3.07M 0.04% 497
2021
Q3 		$11.7M Sell
2,066,666
-800,076
-28% -$4.62M 0.03% 697
2021
Q2 		$18.9M Buy
2,866,742
+306,113
+12% +$2.14M 0.04% 511
2021
Q1 		$20.7M Buy
2,560,629
+529,759
+26% +$4.33M 0.05% 421
2020
Q4 		$13.1M Buy
2,030,870
+391,428
+24% +$2.28M 0.04% 500
2020
Q3 		$5.9M Buy
1,639,442
+553,789
+51% +$2.24M 0.02% 730
2020
Q2 		$4.99M Sell
1,085,653
-23,157
-2% -$98.5K 0.02% 646
2020
Q1 		$3.78M Buy
1,108,810
+113,176
+11% +$495K 0.03% 631
2019
Q4 		$5.08M Buy
995,634
+817,383
+459% +$2.77M 0.02% 939
2019
Q3 		$431K Sell
178,251
-428,678
-71% -$1.14M ﹤0.01% 2673
2019
Q2 		$1.32M Sell
606,929
-8,051
-1% -$19K ﹤0.01% 1734
2019
Q1 		$1.67M Sell
614,980
-491,899
-44% -$2.13M 0.01% 1528
2018
Q4 		$5.31M Buy
1,106,879
+1,068,008
+2,748% +$6.48M 0.02% 768
2018
Q3 		$368K Buy
+38,871
New +$374K ﹤0.01% 2645
2018
Q2 		– Sell
-223,216
Closed -$2.35M – 3760
2018
Q1 		$2.35M Sell
223,216
-796,873
-78% -$7.87M 0.01% 1417
2017
Q4 		$6.54M Buy
1,020,089
+640,669
+169% +$3.95M 0.02% 787
2017
Q3 		$2.9M Buy
379,420
+330,953
+683% +$2.2M 0.01% 1104
2017
Q2 		$345K Buy
+48,467
New +$222K ﹤0.01% 2566
2017
Q1 		– Sell
-347,034
Closed -$708K – 3427
2016
Q4 		$708K Sell
347,034
-6,542
-2% -$13.1K ﹤0.01% 2256
2016
Q3 		$948K Sell
353,576
-617,319
-64% -$1.8M ﹤0.01% 1990
2016
Q2 		$2.99M Buy
+970,895
New +$6.09M 0.01% 1026
2015
Q4 		– Sell
-33,443
Closed -$321K – 3065
2015
Q3 		$321K Buy
33,443
+23,143
+225% +$338K ﹤0.01% 1760
2015
Q2 		$148K Buy
+10,300
New +$113K ﹤0.01% 2671

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Investments's IMGN Position: Q1 2024 in Review

Two Sigma Investments sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 363,900 shares — an estimated $10.8M sold.

Two Sigma Investments first reported a position in IMGN in Q2 2015 and held it in 31 quarters. The position peaked at $25.8M in Q3 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Two Sigma Investments reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Investments sold 363,900 Immunogen Inc shares in Q1 2024, an estimated $10.8M.
  • Two Sigma Investments first reported a position in Immunogen Inc in Q2 2015 and held it in 31 quarters.
  • Two Sigma Investments's Immunogen Inc position peaked at $25.8M in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.